Factors Governing the Accuracy of Subvisible Particle Counting Methods.

A number of new techniques for subvisible particle characterization in biotechnological products have emerged in the last decade. Although the pharmaceutical community is actively using them, the current knowledge about the analytical performance of some of these tools is still inadequate to support their routine use in the development of biopharmaceuticals (especially in the case of submicron methods). With the aim of increasing this knowledge and our understanding of the most prominent techniques for subvisible particle characterization, this study reports the results of a systematic evaluation of their accuracy. Our results showed a marked overcounting effect especially for low concentrated samples and particles fragile in nature. Furthermore, we established the relative sample size distribution as the most important contributor to an instrument's performance in accuracy counting. The smaller the representation of a particle size within a solution, the more difficulty the instruments had in providing an accurate count. These findings correlate with a recent study examining the principal factors influencing the precision of the subvisible particle measurements. A more thorough understanding of the capabilities of the different particle characterization methods provided here will help guide the application of these methods and the interpretation of results in subvisible particle characterization studies.

[1]  S. Singh,et al.  An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. , 2010, Journal of pharmaceutical sciences.

[2]  Wei Wang,et al.  Immunogenicity of protein aggregates--concerns and realities. , 2012, International journal of pharmaceutics.

[3]  W. Jiskoot,et al.  Light Obscuration Measurements of Highly Viscous Solutions: Sample Pressurization Overcomes Underestimation of Subvisible Particle Counts , 2014, The AAPS Journal.

[4]  J. Carpenter,et al.  Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins. , 2015, Journal of pharmaceutical sciences.

[5]  John F. Carpenter,et al.  Analytical approaches to assess the degradation of therapeutic proteins , 2013 .

[6]  G. Winter,et al.  How subvisible particles become invisible-relevance of the refractive index for protein particle analysis. , 2013, Journal of pharmaceutical sciences.

[7]  Steven Kozlowski,et al.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.

[8]  D. K. Sharma,et al.  Micro-Flow Imaging: Flow Microscopy Applied to Sub-visible Particulate Analysis in Protein Formulations , 2010, The AAPS Journal.

[9]  Patrick Garidel,et al.  Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development , 2010, Pharmaceutical Research.

[10]  A. Koulov,et al.  Factors Governing the Precision of Subvisible Particle Measurement Methods – A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe , 2015, Pharmaceutical Research.

[11]  M. Manning,et al.  Flow imaging: moving toward best practices for subvisible particle quantitation in protein products. , 2013, Journal of pharmaceutical sciences.

[12]  John F Carpenter,et al.  Critical evaluation and guidance for using the Coulter method for counting subvisible particles in protein solutions. , 2012, Journal of pharmaceutical sciences.

[13]  M. Peterka,et al.  Evaluation of nanoparticle tracking analysis for total virus particle determination , 2012, Virology Journal.

[14]  W. Jiskoot,et al.  Micro-flow imaging and resonant mass measurement (Archimedes)--complementary methods to quantitatively differentiate protein particles and silicone oil droplets. , 2013, Journal of pharmaceutical sciences.

[15]  Doris W Lau,et al.  Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator. , 2012, Analytical chemistry.

[16]  S. Manalis,et al.  Weighing of biomolecules, single cells and single nanoparticles in fluid , 2007, Nature.

[17]  S. Manalis,et al.  Integrated measurement of the mass and surface charge of discrete microparticles using a suspended microchannel resonator. , 2009, Analytical chemistry.

[18]  L. Narhi,et al.  A critical review of analytical methods for subvisible and visible particles. , 2009, Current pharmaceutical biotechnology.

[19]  G. Vayopoulos,et al.  Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations , 2012, Virology Journal.

[20]  Matthew N. Rhyner The Coulter Principle for Analysis of Subvisible Particles in Protein Formulations , 2011, The AAPS Journal.

[21]  M. Sukumar,et al.  Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. , 2010, Journal of pharmaceutical sciences.

[22]  J. Carpenter,et al.  Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity. , 2013, Journal of pharmaceutical sciences.

[23]  Daniela Verthelyi,et al.  Managing uncertainty: a perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins. , 2012, Journal of pharmaceutical sciences.

[24]  M. Wright Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. , 2012, Methods in molecular biology.

[25]  G. Winter,et al.  Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  A. Koulov,et al.  Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection Capabilities. , 2015, Analytical chemistry.

[27]  D. Volkin,et al.  Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  J. Philo Is any measurement method optimal for all aggregate sizes and types? , 2006, The AAPS Journal.

[29]  A. Koulov,et al.  Discrimination Between Silicone Oil Droplets and Protein Aggregates in Biopharmaceuticals: A Novel Multiparametric Image Filter for Sub-visible Particles in Microflow Imaging Analysis , 2011, Pharmaceutical Research.

[30]  Wim Jiskoot,et al.  Particles in therapeutic protein formulations, Part 1: overview of analytical methods. , 2012, Journal of pharmaceutical sciences.

[31]  D. Volkin,et al.  Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data. , 2015, Journal of pharmaceutical sciences.

[32]  T. Arvinte,et al.  Addressing new analytical challenges in protein formulation development. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  W. Jiskoot,et al.  Flow Imaging Microscopy for Protein Particle Analysis—A Comparative Evaluation of Four Different Analytical Instruments , 2013, The AAPS Journal.

[34]  S. Shire,et al.  Characterization of Particles in Protein Solutions: Reaching the Limits of Current Technologies , 2010, The AAPS Journal.

[35]  Elizabeth M. Topp,et al.  Analyzing Subvisible Particles in Protein Drug Products: a Comparison of Dynamic Light Scattering (DLS) and Resonant Mass Measurement (RMM) , 2014, The AAPS Journal.

[36]  S. Mathew,et al.  Characterization of submicron (0.1-1 μm) particles in therapeutic proteins by nanoparticle tracking analysis. , 2015, Journal of pharmaceutical sciences.

[37]  Vasco Filipe,et al.  Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates , 2010, Pharmaceutical Research.

[38]  A. Mire-Sluis,et al.  Sub-visible particle quantitation in protein therapeutics. , 2009, Pharmeuropa bio & scientific notes.